Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool, which complements other stroke screening technology such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA) and computed tomography angiography (CTA). The CSS is non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by oldtimer42on Mar 10, 2020 4:03pm
104 Views
Post# 30790075

RE:RE:Who Cares?

RE:RE:Who Cares?

Growth100Percent, it is only my opinion but we would be financed in the US. They love biotech startups. Remember, we were probably only 203 clinical trial tests to get us to FDA approval yet Peter screwed that up. All it takes in the US is some hype in the stock and funding is easy....you just have to surrender a large chunk of the company. I am OK with that. The OTC is the hotbed of startup biotechs. I was in one that went from $3 to $12 in one day on the OTC. It is now $1.90 and still has not had clinical trials 2 years later. 

 

Our fools just have to show a modest degree of management competence and organization and get to FDA submission and we will be fine. This power struggle has done us no good, but I doubt we will ever trade again on the TSX.

 

By the way Hack’s replacement is very qualified and brought on board in one day...there was a game played that we were not privy to. He and others were party to this so maybe we are now on the right track.

Bullboard Posts